The PTEN and INK4A/ARF tumor suppressors maintain myelolymphoid homeostasis and cooperate to constrain histiocytic sarcoma development in humans-Reference-Cited by-同舟云学术

The PTEN and INK4A/ARF tumor suppressors maintain myelolymphoid homeostasis and cooperate to constrain histiocytic sarcoma development in humans

Published:2006-05 Issue:5 Volume:9 Page:379-390
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Carrasco Daniel R.,Fenton Tim,Sukhdeo Kumar,Protopopova Marina,Enos Miriam,You Mingjian J.,Divicio Dolores,Nogueira Cristina,Stommel Jayne,Pinkus Geraldine S.,Fletcher Christopher,Hornick Jason L.,Cavenee Webster K.,Furnari Frank B.,DePinho Ronald A.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference53 articles.

1. Chapter 10: Histiocytic and Dendritic Cell Neoplasms;Banks,2001

2. Classification of acute leukemias;Brunning;Semin. Diagn. Pathol.,2003

3. Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer;Burri;Lab. Invest.,2001

4. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway;Cantley;Proc. Natl. Acad. Sci. USA,1999

5. Histiocytes and histiocytosis;Cline;Blood,1994

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive review of the PTEN/PI3K/Akt axis in multiple myeloma: From molecular interactions to potential therapeutic targets;Pathology - Research and Practice;2024-08

2. One Health: Therapies Targeting Genetic Variants in Human and Canine Histiocytic and Dendritic Cell Sarcomas;Veterinary and Comparative Oncology;2024-06-12

3. Transformation of primary murine peritoneal mast cells by constitutive KIT activation is accompanied by loss of Cdkn2a/Arf expression;Frontiers in Immunology;2023-03-30

4. Transformation of primary murine peritoneal mast cells by constitutive KIT activation as a result of lostCdkn2a/Arfexpression;2023-01-24

5. Sirolimus as frontline therapy for PTEN-mutated histiocytic sarcoma;Haematologica;2022-12-07